Bulimia Nervosa
📧 Sign up to get email alerts when something new happens for Bulimia Nervosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: A Longitudinal Study of Severe and Enduring Eating Disorders
A longitudinal clinical trial update about a study recruiting participants with severe and enduring eating disorders, including anorexia ner…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Multimodal Longitudinal and Predictive Modelling to Understand Eating Disorder Development
A completed clinical trial from King's College London studying multimodal longitudinal and predictive modeling to understand the development…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Avoidance-driven Decision Making and Learning in Anorexia Nervosa and Bulimia Nervosa
This trial update describes a recruiting study from UC San Diego investigating avoidance-driven decision making and learning in individuals …
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Exploring the Full Body Representation in Anorexia Nervosa and Bulimia Nervosa
A clinical trial update from Istituto Auxologico Italiano describes a study on full body representation in individuals with anorexia nervosa…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: The Effects of Heart Rate Variability Biofeedback on College Students With Disordered Eating [NA]
A completed study from Arizona State University evaluating heart rate variability biofeedback in college students with disordered eating to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Unfolding Severe and Enduring Eating Disorders (U-SEED)
Clinical Trial Update: U-SEED is a study at Uppsala University Hospital investigating severe and enduring eating disorders and is currently …
-
FDA approval · 2024-09-13FDA Approved: FLUOXETINE HCL — Original Application (Strides Pharma Science Limited)
FDA approved a generic fluoxetine hydrochloride product from Strides Pharma Science Limited via an original ANDA. The approval confirms the …
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Pre-therapeutic Validation of the Virtual Reality-based Exposure Scenario for CBT "ReVBED" for the Induction of Food Craving in Patients With Bulimia and Binge Eating Disorder (BED) [NA]
This completed clinical trial evaluates the pre-therapeutic validation of a virtual reality-based exposure scenario (ReVBED) for cognitive b…
-
FDA approval · 2024-08-29FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved the supplemental application for Fluoxetine Hydrochloride from Taro Pharmaceuticals U.S.A., Inc. (ANDA211477), enabling the mar…
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating [NA]
Clinical trial update describing a Drexel University study evaluating technological augmentations to enhance outcomes of self-help cognitive…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Pilot Study on the Validity of the Metacognitive Hub Model of Craving in Bulimia Nervosa (BN) and Binge Eating Disorders (BED)
A pilot study is underway to evaluate the validity of the Metacognitive Hub Model of Craving in Bulimia Nervosa and Binge-Eating Disorder, a…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Feasibility of the ROADE Program [NA]
This clinical trial update reports the feasibility of the ROADE Program and indicates the trial has been terminated.
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program [NA]
A trial update for the MINERVA program, a new treatment program for adolescents with eating disorders, currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Feasibility Trial of Getting Better Bite by Bite for Eating Disorders [NA]
A feasibility study titled 'Getting Better Bite by Bite' for eating disorders, including bulimia nervosa and binge-eating disorder, conducte…
-
FDA approval · 2024-05-02FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for the generic fluoxetine from Aurobindo Pharma Limited (ANDA213265).
-
FDA approval · 2024-04-05FDA Approved: FLUOXETINE — Original Application (Strides Pharma Science Limited)
FDA approved an Original Application for a generic Fluoxetine from Strides Pharma Science Limited, enabling a generic version of fluoxetine …
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic [NA]
Completed clinical trial evaluating Reward Re-Training for reward imbalance in bulimia nervosa and related eating disorders; results posted …
-
FDA approval · 2024-01-09FDA Approved: FLUOXETINE — Supplemental Application (Vensun Pharmaceuticals, Inc.)
FDA approved a supplemental application for fluoxetine hydrochloride from Vensun Pharmaceuticals, Inc., granting approval of a generic fluox…
-
FDA approval · 2024-01-03FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for fluoxetine hydrochloride.
-
FDA approval · 2023-12-19FDA Approved: FLUOXETINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine by Alembic Pharmaceuticals Limited.
-
FDA approval · 2023-11-20FDA Approved: FLUOXETINE — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for fluoxetine submitted by Endo USA, Inc., resulting in regulatory changes to the product's sta…
-
FDA approval · 2023-11-15FDA Approved: FLUOXETINE — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for fluoxetine (generic) from Micro Labs Limited under an ANDA.
-
FDA approval · 2023-09-19FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for fluoxetine submitted by Aurobindo Pharma Limited. This action updates the regulatory status …
-
FDA approval · 2023-08-21FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for fluoxetine hydrochloride (generic fluoxetine) submitted by PAI Holdings, dba PAI Pharma.
-
FDA approval · 2023-08-21FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for fluoxetine hydrochloride (ANI Pharmaceuticals, Inc.), indicating approval of changes to an alrea…